114
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

The HPLC–MS/MS Method for Determination of Diosbulbin B in the Plasma of Rats Administered with Rhizoma Dioscoreae Bulbiferae Combinations: Application to Comparative Pharmacokinetic Study

, , &
 

Abstract

Diosbulbin B (DB) is a diterpenoid lactone with a remarkable anticancer effect isolated from Rhizoma Dioscoreae Bulbiferae (RDB). The present study aimed to develop a new and sensitive method for determination of DB in rats after oral administration of single herb RDB decoction and its three combinations with Radix Angelicae Sinensis (RAS). A sensitive and rapid liquid chromatography–tandem mass spectrometry (LC–MS/MS) method with a multiple-reaction monitoring (MRM) mode was employed for quantification of DB in the rat plasma. DB and spinosin (internal standard, IS) were separated on an Xtimate C18 column (4.6 mm × 150 mm, 5 µm) using a gradient mobile phase consisting of water and acetonitrile. The calibration curve was linear over the range of 0.5 to 500 ng/mL. The lower limit of quantification was 0.5 ng/mL. The accuracy and precision of DB in the rat plasma were between −4.2% and 8.1% relative error, and 3.2% to 9.1% relative standard deviation, respectively. The fully validated method was successfully applied to comparative pharmacokinetics (PK) of DB in RDB–RAS combinations. The results showed that components in RAS had a dramatic effect on the PK pattern of DB.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.